Stock listing

OTC:VINC Vincerx Pharma Inc Stock

Follow Vincerx Pharma Inc into a list and get an email when it puts out news.

Share price · OTC:VINC

$0.016 USD 0.000 (0.0%)

Close on Nov 20, 2026

Past year +58.4% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$0.016 – $0.016 USDNov 20, 2026
Volume
479 sharesNov 20, 2026
Market cap
$83,748 USDAt the close on Nov 20, 2026 · price × 5.23M shares outstanding
52-week range
$0.010 – $0.026 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$24 USDMedian day 500 shares · last 3 months, Aug 26, 2026 – Nov 20, 2026
Vincerx Pharma Inc logo

Daily closes

Last 3 months, Aug 26, 2026 – Nov 20, 2026 · OTC:VINC · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.0160.0000.0%$0.016$0.016$0.016479
$0.016+0.001+6.7%$0.016$0.016$0.0161,216
$0.0150.0000.0%$0.015$0.015$0.015663
$0.0150.0000.0%$0.015$0.015$0.0155,500
$0.0150.0000.0%$0.015$0.015$0.0152,111
$0.0150.0000.0%$0.015$0.015$0.015177
$0.0150.0000.0%$0.015$0.015$0.0151,070
$0.0150.0000.0%$0.015$0.015$0.0151,870
$0.0150.0000.0%$0.015$0.015$0.015428
$0.0150.0000.0%$0.015$0.015$0.0151,000
$0.0150.0000.0%$0.015$0.015$0.015175
$0.0150.0000.0%$0.015$0.015$0.0152,205
$0.0150.0000.0%$0.015$0.015$0.015251
$0.0150.0000.0%$0.015$0.015$0.015460
$0.015-0.011-41.6%$0.015$0.015$0.0151
$0.026+0.011+71.3%$0.015$0.026$0.01510,977
$0.0150.0000.0%$0.015$0.015$0.015101
$0.0150.0000.0%$0.015$0.015$0.015104
$0.0150.0000.0%$0.015$0.015$0.015801
$0.0150.0000.0%$0.015$0.015$0.015200
$0.0150.0000.0%$0.015$0.015$0.015500
$0.0150.0000.0%$0.015$0.015$0.0151,029
$0.0150.0000.0%$0.015$0.015$0.015250
$0.0150.0000.0%$0.015$0.015$0.015254
$0.0150.0000.0%$0.015$0.015$0.0151,682
$0.0150.0000.0%$0.015$0.015$0.0151,784
$0.0150.0000.0%$0.015$0.015$0.015340
$0.0150.0000.0%$0.015$0.015$0.015365
$0.015+0.002+14.5%$0.015$0.015$0.015151
$0.0130.0000.0%$0.013$0.013$0.013614
$0.013+0.000+3.1%$0.013$0.013$0.0138,000
$0.0130.0000.0%$0.013$0.013$0.013385
$0.0130.0000.0%$0.013$0.013$0.013733

Splits

1 split · OTC:VINC · every price before a split is adjusted for it

DayRatioWhat
1-for-20Consolidation
Ticker
OTC:VINC
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
OTC
Currency
USD

Vincerx Pharma Inc on 6ix

Sector
Health care
Industry
Biotechnology
Decks
2 decks · latest Jan 23, 2025

Valuation

price Nov 20, 2026

Enterprise value
No statements on 6ix yet
P/E
No statements on 6ix yet
EV/sales
No statements on 6ix yet
EV/EBITDA
No statements on 6ix yet
Price/book
No statements on 6ix yet
Gross margin
No statements on 6ix yet
Operating margin
No statements on 6ix yet
Net margin
No statements on 6ix yet
Debt to equity
No statements on 6ix yet
Beta vs S&P 500
0.69

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Vincerx Pharma Inc · OTC:VINCUS$83,748n/an/an/an/an/an/an/a0.69
Vaxil Bio Ltd. · TSXV:VXLUS$319,500−US$4,0701.2×n/an/a0.4×n/a0.0×-0.16
Chimeric Therapeutics Limited · ASX:CHMUS$292,816−US$220,193n/a−0.1×n/a0.2×−262.8%2.5×n/a
CERo Therapeutics Holdings, Inc. · OTC:CEROUS$265,035−US$190,890n/an/an/an/an/an/a1.47
CDT Equity Inc. · NASDAQ:CDTUS$234,109−US$1.49Mn/an/an/a0.0×n/a0.0×1.14
GlucoTrack, Inc. · NASDAQ:GCTKUS$217,049−US$887,951n/an/an/an/an/an/a1.73
Regen BioPharma, Inc. · OTC:RGBPUS$167,528US$167,289n/a0.7×n/an/a−501.4%n/a1.20
CNBX Pharmaceuticals Inc. · OTC:CNBXUS$160,577US$151,090n/an/an/an/an/an/a1.78
Fifty 1 Labs Inc. · OTC:FITYUS$118,532US$282,021n/a6,000×n/an/an/an/a-1.17
GB Sciences, Inc. · OTC:GBLXUS$81,414US$2.07Mn/an/an/an/an/an/a-0.46
Lyra Therapeutics, Inc. · OTC:LYRAUS$53,246US$14.42Mn/a36.2×n/an/an/an/a0.67
Median of the othersUS$192,289US$73,5101.2×18.5×0.2×−382.1%0.0×1.14

Events

QuarterResultsShare move
Q1 2025May 12, 2025 · Before open+4.4%
Q4 2024Mar 27, 2025 · After close−4.8%
Q3 2024Nov 12, 2024 · Before open−3.5%
Q2 2024Aug 8, 2024 · After close−7.5%
Q1 2024May 14, 2024 · After close−2.2%
Q4 2023Mar 29, 2024 · After close+15.6%
Q3 2023Nov 14, 2023 · Before open−9.0%
Q2 2023Aug 7, 2023 · Before open−2.2%
Q1 2023May 11, 2023 · After close−1.8%
Q4 2022Mar 28, 2023 · After close+7.4%
All 18 quarters
QuarterResultsShare move
Q3 2022Nov 10, 2022 · After close−10.2%
Q2 2022Aug 11, 2022 · After close+6.8%
Q1 2022May 12, 2022 · After close−6.1%
Q4 2021Mar 29, 2022 · Before open−5.0%
Q3 2021Nov 12, 2021 · Before open−0.7%
Q2 2021Aug 12, 2021 · After close+10.5%
Q1 2021May 17, 2021 · Before open−2.6%
Q4 2020Mar 22, 2021 · Before open−3.1%

Open Events

Decks

DeckKindSlidesDate
Merger or Acquisition (January 2025)Merger or acquisition23 slidesJan 23, 2025
LifeSci Acquisition — SPAC Merger (September 2020)SPAC merger35 slidesSep 29, 2020

Open Decks

Financials

Annual, in USD

Income statement

LineFY2024FY2023FY2022FY2021FY2020FY2019
Revenue00000
Cost of revenue1.09M915.0K939.0K340.0K173.0K173.0K
Gross profit-1.09M-915.0K-939.0K-340.0K-173.0K-173.0K
Research and development15.5M28.1M52.2M40.1M7.12M
Selling, general and administrative16.0M13.6M19.0M22.6M3.60M54.0K
Operating income-31.5M-42.6M-68.7M-62.7M-10.7M-45.0K
Depreciation and amortization1.09M915.0K939.0K340.0K20.0K54.0K
EBITDA-30.4M-41.7M-67.8M-62.3M-10.7M9.00K
Interest expense8.21M23.4M8.00K0
Income before tax-30.1M-40.2M-63.0M-39.3M-10.7M-45.0K
Income tax-8.21M-23.7M8.00K-54
Net income-30.1M-40.2M-65.4M-39.3M-10.7M-54.0K
Earnings per share, basic-5.75-6.84-11.27-8.30-7.53-0.04

Balance sheet

LineFY2024FY2023FY2022FY2021FY2020FY2019
Cash and equivalents4.99M12.8M11.7M111.5M61.8M684.7K
Short-term investments040.8M0
Receivables1.04M1.04M1.37M
Inventory-1.24M
Current assets6.41M14.7M56.0M111.8M63.1M791.0K
Property, plant and equipment3.24M4.18M
Total assets8.01M18.2M59.3M117.7M63.2M1.00K
Accounts payable2.03M2.50M4.07M2.02M491.0K35.0K
Current liabilities5.28M5.61M9.16M13.9M37.8M44.0K
Total debt2.50M3.44M4.17M
Total liabilities5.28M7.00M11.6M17.4M5.50M44.0K
Shareholders' equity2.72M11.2M47.7M100.3M25.4M-44.0K
Shares outstanding5.23M5.87M5.80M4.74M1.42M1.43M

Cash flow

LineFY2024FY2023FY2022FY2021FY2020FY2019
Cash from operations-26.1M-40.5M-59.6M-33.4M-2.28M-35.0K
Capital spending000-5.26M-258.0K-258.0K
Free cash flow-26.1M-40.5M-59.6M-38.7M-2.28M-35.0K
Cash from investing212.0K41.5M-40.6M-5.26M-65.6M-65.6M
Cash from financing18.0M114.0K280.0K88.5M64.1M66.5M
Share buybacks1.00K
Change in cash-7.79M1.12M-99.8M49.8M61.8M790.0K

Open Financials

Cap table

Built by 6ix from Vincerx Pharma Inc’s releases

Common shares
5,234,277
Fully diluted
5,234,277

Fully diluted

LineShares
Common shares5,234,277

Share count over time

CountShares
Nov 22, 20265,234,277

Open Cap table

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Ahmed Hamdy
Other companies: Curis, Inc. (Chief Medical Officer · Since at least May 1, 2025)
Chief Executive Officer, Director · Jun 29, 2021 – Aug 12, 2024 · Past
Francisco Salva
Other companies: Azitra Inc (President and CEO · Since at least Jun 15, 2023)
Director · May 13, 2021 – May 23, 2024 · Past
Hermes de Jesus GarbanChief Medical Officer · Mar 1, 2021 – Feb 14, 2022 · Past
Kevin HaasActing Chief Financial Officer · Dec 20, 2024 – Dec 20, 2024 · Past
Sooin HwangChief Business Officer · May 13, 2021 – Feb 14, 2022 · Past

Open People

Log in to ask 6ix AI your own questions about Vincerx Pharma Inc.